On August 25, the High Commission of India, in association with Pharmexcil, successfully organised a hybrid webinar on India–Malawi Cooperation in the Pharmaceutical sector in Lilongwe.

The programme brought together the Central Medical Stores Trust (CMST), the Pharmacy and Medicines Regulatory Authority (PMRA), Govt of Malawi, and Indian and Malawian pharmaceutical companies for productive discussions on drug registration/licenses , business opportunities, B2B engagements and partnerships.

Mr. Raja Bhanu, DG, Pharmexcil, highlighted the upcoming Pharma expo- iPHEX2026 and sought Malawi’s participation in expo, while Dr. Moses Chisale, CEO, CMST, briefed participants on Malawi’s drug registration procedures and the immense potential in the pharmaceutical sector.

H.E. Mr. Amararam Gujar, High Commissioner of India, welcomed the growing pharmaceutical cooperation between two countries and encouraged the CMST and other Malawian Pharma companies to source their requirements of medicines and Pharma drugs from India given Indian pharma products’s cost effectiveness , affordability, and quality standards. High Commissioner also urged Indian companies to forge Joint venture partnerships with Malawian businesses in local pharmaceutical production facilities and tap the wider SADC market. High Commissioner underscored the ample scope for further strengthening cooperation in pharma sector under the framework of signed MOU in pharmacopeia with Malawi.He extended best wishes to Pharmexcil for the forthcoming iPHEX 2026 as more than half a dozen Malawian companies are participating in iPHEX from Sept 7-9 in #BharatMandapam in New Delhi.